Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer Using Cell-free DNA Fragmentomics

Currently, approximately 30%–55% of the patients with non–small cell lung cancer (NSCLC) develop recurrence due to minimal residual disease (MRD) after receiving surgical resection of the tumor. This study aims to develop an ultrasensitive and affordable fragmentomic assay for MRD detection in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Siwei, Xia, Zhijun, You, Jing, Gu, Xiaolan, Meng, Fanchen, Chen, Peng, Tang, Wanxiangfu, Bao, Hua, Zhang, Jingyuan, Wu, Xue, Shao, Yang, Wang, Jie, Zuo, Xianglin, Xu, Lin, Yin, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228550/
https://www.ncbi.nlm.nih.gov/pubmed/37377889
http://dx.doi.org/10.1158/2767-9764.CRC-22-0363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228550/
https://www.ncbi.nlm.nih.gov/pubmed/37377889
http://dx.doi.org/10.1158/2767-9764.CRC-22-0363

Ejemplares similares